[96a5a0]: / output / allTrials / identified / NCT01087580_identified.json

Download this file

205 lines (205 with data), 8.4 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
{
"info": {
"nct_id": "NCT01087580",
"official_title": "A Randomized Phase-II Pilot Trial of Docetaxel and Prednisone Versus Radiation Therapy Plus Docetaxel and Prednisone in Patients With Nonmetastatic and Oligometastatic Castrate Resistant Prostate Cancer",
"inclusion_criteria": "* Participants must have a diagnosis of castrate resistant prostate cancer.\n* Participants must be 18 years old or older.\n* Biopsy of tissue from the prostate or enlarged lymph nodes may be required.\n* Patients must sign study specific informed consent prior to study entry.\n* Men of child-producing potential must be willing to consent to use effective contraception while on treatment and for at least 3 months afterwards.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Participants cannot have prior chemotherapy for prostate cancer.\n* Participants cannot have prior radiation therapy to the pelvis.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Participants must have a diagnosis of castrate resistant prostate cancer.",
"criterions": [
{
"exact_snippets": "diagnosis of castrate resistant prostate cancer",
"criterion": "castrate resistant prostate cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "* Participants must be 18 years old or older.",
"criterions": [
{
"exact_snippets": "Participants must be 18 years old or older.",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Biopsy of tissue from the prostate or enlarged lymph nodes may be required.",
"criterions": [
{
"exact_snippets": "Biopsy of tissue from the prostate ... may be required.",
"criterion": "biopsy of prostate tissue",
"requirements": [
{
"requirement_type": "requirement",
"expected_value": "may be required"
}
]
},
{
"exact_snippets": "Biopsy of tissue from ... enlarged lymph nodes may be required.",
"criterion": "biopsy of enlarged lymph nodes",
"requirements": [
{
"requirement_type": "requirement",
"expected_value": "may be required"
}
]
}
]
},
{
"line": "* Patients must sign study specific informed consent prior to study entry.",
"criterions": [
{
"exact_snippets": "Patients must sign study specific informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "* Men of child-producing potential must be willing to consent to use effective contraception while on treatment and for at least 3 months afterwards.",
"criterions": [
{
"exact_snippets": "Men of child-producing potential",
"criterion": "child-producing potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "must be willing to consent to use effective contraception",
"criterion": "willingness to use contraception",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "while on treatment and for at least 3 months afterwards",
"criterion": "duration of contraception use",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "while on treatment and for at least 3 months afterwards"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Participants cannot have prior chemotherapy for prostate cancer.",
"criterions": [
{
"exact_snippets": "Participants cannot have prior chemotherapy for prostate cancer.",
"criterion": "prior chemotherapy for prostate cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Participants cannot have prior radiation therapy to the pelvis.",
"criterions": [
{
"exact_snippets": "prior radiation therapy to the pelvis",
"criterion": "prior radiation therapy to the pelvis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}